Pathway ID | hsa05166 |
Pathway Term | HTLV-I infection |
Pathway Source | KEGG |
Gene Symbol | Description | Entrez ID | Uniprot ID | Chromosomal Location |
---|---|---|---|---|
AKT3 |
v-akt murine thymoma viral oncogene homolog 3 |
10000 |
Q9Y243 |
chr1: 243,488,233-243,851,079 |
CDK4 |
cyclin-dependent kinase 4 |
1019 |
P11802 |
chr12: 57,747,727-57,756,013 |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
1026 |
P38936 |
chr6: 36,676,460-36,687,339 |
CDKN2B |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
1030 |
P42772 |
chr9: 22,002,903-22,009,363 |
CDKN2C |
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
1031 |
P42773 |
chr1: 50,960,745-50,974,633 |
ANAPC10 |
anaphase promoting complex subunit 10 |
10393 |
Q9UM13 |
chr4: 144,831,908-145,098,541 |
POLD3 |
polymerase (DNA-directed), delta 3, accessory subunit |
10714 |
Q15054 |
chr11: 74,493,851-74,669,117 |
ADCY3 |
adenylate cyclase 3 |
109 |
O60266 |
chr2: 24,819,169-24,919,839 |
CHEK1 |
checkpoint kinase 1 |
1111 |
O14757 |
chr11: 125,625,136-125,676,255 |
ADCY7 |
adenylate cyclase 7 |
113 |
P51828 |
chr16: 50,246,137-50,318,135 |
ADCY9 |
adenylate cyclase 9 |
115 |
O60503 |
chr16: 3,953,387-4,116,185 |
CREB1 |
cAMP responsive element binding protein 1 |
1385 |
P16220 |
chr2: 207,529,737-207,603,431 |
CREBBP |
CREB binding protein |
1387 |
Q92793 |
chr16: 3,725,054-3,880,726 |
CREM |
cAMP responsive element modulator |
1390 |
Q03060 |
chr10: 35,126,791-35,212,958 |
CTNNB1 |
catenin beta 1 |
1499 |
P35222 |
chr3: 41,194,837-41,260,096 |
DLG1 |
discs, large homolog 1 (Drosophila) |
1739 |
Q12959 |
chr3: 197,042,560-197,299,300 |
E2F1 |
E2F transcription factor 1 |
1869 |
Q01094 |
chr20: 33,675,683-33,686,404 |
E2F2 |
E2F transcription factor 2 |
1870 |
Q14209 |
chr1: 23,506,430-23,531,220 |
EGR1 |
early growth response 1 |
1958 |
P18146 |
chr5: 138,465,490-138,469,315 |
EGR2 |
early growth response 2 |
1959 |
P11161 |
chr10: 62,811,996-62,919,900 |
ELK1 |
ELK1, member of ETS oncogene family |
2002 |
P19419 |
chrX: 47,635,521-47,650,604 |
EP300 |
E1A binding protein p300 |
2033 |
Q09472 |
chr22: 41,091,786-41,180,079 |
AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
207 |
P31749 |
chr14: 104,769,349-104,795,751 |
AKT2 |
v-akt murine thymoma viral oncogene homolog 2 |
208 |
P31751 |
chr19: 40,230,317-40,285,536 |
ETS1 |
v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
2113 |
P14921 |
chr11: 128,458,761-128,587,558 |
ETS2 |
v-ets avian erythroblastosis virus E26 oncogene homolog 2 |
2114 |
P15036 |
chr21: 38,805,307-38,824,955 |
FDPS |
farnesyl diphosphate synthase |
2224 |
P14324 |
chr1: 155,308,748-155,320,666 |
RRAS2 |
related RAS viral (r-ras) oncogene homolog 2 |
22800 |
P62070 |
chr11: 14,277,926-14,364,506 |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
2353 |
P01100 |
chr14: 75,278,774-75,282,230 |
GPS2 |
G protein pathway suppressor 2 |
2874 |
Q13227 |
chr17: 7,311,324-7,315,564 |
SLC25A4 |
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 |
291 |
P12235 |
chr4: 185,143,241-185,150,382 |
SLC25A5 |
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 |
292 |
P05141 |
chrX: 119,468,400-119,471,319 |
GSK3B |
glycogen synthase kinase 3 beta |
2932 |
P49841 |
chr3: 119,821,323-120,094,417 |
ANAPC4 |
anaphase promoting complex subunit 4 |
29945 |
Q9UJX5 |
chr4: 25,377,213-25,418,498 |
HLA-A |
major histocompatibility complex, class I, A |
3105 |
P30443 |
chr6: 29,941,260-29,945,884 |
HLA-B |
major histocompatibility complex, class I, B |
3106 |
P01889 |
chr6: 31,269,491-31,357,188 |
HLA-C |
major histocompatibility complex, class I, C |
3107 |
P30499 |
chr6: 31,268,749-31,272,130 |
HLA-DMA |
major histocompatibility complex, class II, DM alpha |
3108 |
P28067 |
chr6: 32,948,613-32,969,094 |
HLA-DMB |
major histocompatibility complex, class II, DM beta |
3109 |
P28068 |
chr6: 32,934,629-32,941,070 |
HLA-DOB |
major histocompatibility complex, class II, DO beta |
3112 |
P13765 |
chr6: 32,812,763-32,817,048 |
HLA-DPA1 |
major histocompatibility complex, class II, DP alpha 1 |
3113 |
P20036 |
chr6: 33,064,569-33,080,775 |
HLA-DQA1 |
major histocompatibility complex, class II, DQ alpha 1 |
3117 |
P01909 |
chr6: 32,628,179-32,647,062 |
HLA-DQA2 |
major histocompatibility complex, class II, DQ alpha 2 |
3118 |
P01906 |
chr6: 32,741,342-32,747,215 |
HLA-DQB1 |
major histocompatibility complex, class II, DQ beta 1 |
3119 |
P01920 |
chr6: 32,659,467-32,668,383 |
HLA-DRA |
major histocompatibility complex, class II, DR alpha |
3122 |
P01903 |
chr6: 32,439,842-32,445,046 |
HLA-DRB1 |
major histocompatibility complex, class II, DR beta 1 |
3123 |
P04229 |
chr6: 32,578,769-32,589,848 |
HLA-DRB3 |
major histocompatibility complex, class II, DR beta 3 |
3125 |
P79483 |
chr6: 32,444,128-32,457,245 |
HLA-DRB4 |
major histocompatibility complex, class II, DR beta 4 |
3126 |
P13762 |
chr6: 32,542,598-32,557,561 |
HLA-DRB5 |
major histocompatibility complex, class II, DR beta 5 |
3127 |
Q30154 |
chr6: 32,517,343-32,530,287 |
HLA-E |
major histocompatibility complex, class I, E |
3133 |
P13747 |
chr6: 30,489,467-30,494,205 |
HLA-F |
major histocompatibility complex, class I, F |
3134 |
P30511 |
chr6: 29,722,775-29,738,528 |
HLA-G |
major histocompatibility complex, class I, G |
3135 |
P17693 |
chr6: 29,826,967-29,831,125 |
APC |
adenomatous polyposis coli |
324 |
P25054 |
chr5: 112,707,498-112,846,239 |
XIAP |
X-linked inhibitor of apoptosis |
331 |
P98170 |
chrX: 123,859,724-123,913,979 |
ICAM1 |
intercellular adhesion molecule 1 |
3383 |
P05362 |
chr19: 10,270,835-10,286,615 |
IL1R1 |
interleukin 1 receptor, type I |
3554 |
P14778 |
chr2: 102,064,544-102,179,874 |
IL6 |
interleukin 6 |
3569 |
P05231 |
chr7: 22,725,884-22,732,002 |
ITGB2 |
integrin subunit beta 2 |
3689 |
P05107 |
chr21: 44,885,953-44,931,989 |
JAK1 |
Janus kinase 1 |
3716 |
P23458 |
chr1: 64,833,229-64,966,504 |
JAK3 |
Janus kinase 3 |
3718 |
P52333 |
chr19: 17,824,780-17,848,071 |
JUN |
jun proto-oncogene |
3725 |
P05412 |
chr1: 58,780,788-58,784,327 |
KRAS |
Kirsten rat sarcoma viral oncogene homolog |
3845 |
P01116 |
chr12: 25,204,789-25,250,936 |
LTBR |
lymphotoxin beta receptor |
4055 |
P36941 |
chr12: 6,375,045-6,391,571 |
MAD2L1 |
MAD2 mitotic arrest deficient-like 1 (yeast) |
4085 |
Q13257 |
chr4: 120,055,608-120,067,074 |
SMAD2 |
SMAD family member 2 |
4087 |
Q15796 |
chr18: 47,808,957-47,931,146 |
SMAD3 |
SMAD family member 3 |
4088 |
P84022 |
chr15: 67,063,763-67,195,195 |
SMAD4 |
SMAD family member 4 |
4089 |
Q13485 |
chr18: 51,028,394-51,085,045 |
MYBL1 |
v-myb avian myeloblastosis viral oncogene homolog-like 1 |
4603 |
P10243 |
chr8: 66,562,175-66,614,247 |
MYBL2 |
v-myb avian myeloblastosis viral oncogene homolog-like 2 |
4605 |
P10244 |
chr20: 43,667,019-43,716,496 |
MYC |
v-myc avian myelocytomatosis viral oncogene homolog |
4609 |
P01106 |
chr8: 127,735,434-127,741,434 |
ATF1 |
activating transcription factor 1 |
466 |
P18846 |
chr12: 50,763,710-50,821,122 |
ATF3 |
activating transcription factor 3 |
467 |
P18847 |
chr1: 212,565,334-212,620,777 |
ATF4 |
activating transcription factor 4 |
468 |
P18848 |
chr22: 39,519,695-39,522,685 |
NFATC1 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
4772 |
O95644 |
chr18: 79,395,856-79,529,325 |
NFATC2 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 |
4773 |
Q13469 |
chr20: 51,386,957-51,562,831 |
NFATC4 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 |
4776 |
Q14934 |
chr14: 24,365,673-24,379,604 |
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
4790 |
P19838 |
chr4: 102,501,329-102,617,302 |
NFYB |
nuclear transcription factor Y subunit beta |
4801 |
P25208 |
chr12: 104,117,077-104,138,289 |
NRAS |
neuroblastoma RAS viral (v-ras) oncogene homolog |
4893 |
P01111 |
chr1: 114,704,469-114,716,894 |
PCNA |
proliferating cell nuclear antigen |
5111 |
P12004 |
chr20: 5,114,953-5,126,626 |
ANAPC5 |
anaphase promoting complex subunit 5 |
51433 |
Q9UJX4 |
chr12: 121,308,245-121,399,896 |
PDGFA |
platelet-derived growth factor alpha polypeptide |
5154 |
P04085 |
chr7: 497,258-520,296 |
PDGFB |
platelet-derived growth factor beta polypeptide |
5155 |
P01127 |
chr22: 39,223,359-39,244,751 |
PDGFRA |
platelet-derived growth factor receptor, alpha polypeptide |
5156 |
P16234 |
chr4: 54,229,097-54,298,247 |
PDGFRB |
platelet-derived growth factor receptor, beta polypeptide |
5159 |
P09619 |
chr5: 150,113,837-150,155,872 |
PIK3CA |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
5290 |
P42336 |
chr3: 179,148,114-179,240,093 |
PIK3CB |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta |
5291 |
P42338 |
chr3: 138,652,699-138,834,938 |
PIK3CD |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta |
5293 |
O00329 |
chr1: 9,651,732-9,729,114 |
PIK3R1 |
phosphoinositide-3-kinase regulatory subunit 1 |
5295 |
P27986 |
chr5: 68,215,720-68,301,821 |
POLE3 |
polymerase (DNA directed), epsilon 3, accessory subunit |
54107 |
Q9NRF9 |
chr9: 113,407,235-113,410,672 |
POLD1 |
polymerase (DNA directed), delta 1, catalytic subunit |
5424 |
P28340 |
chr19: 50,384,204-50,418,018 |
POLE |
polymerase (DNA directed), epsilon, catalytic subunit |
5426 |
Q07864 |
chr12: 132,623,753-132,687,365 |
POLE2 |
polymerase (DNA directed), epsilon 2, accessory subunit |
5427 |
P56282 |
chr14: 49,643,555-49,688,422 |
PPP3CA |
protein phosphatase 3, catalytic subunit, alpha isozyme |
5530 |
Q08209 |
chr4: 101,023,409-101,348,278 |
PPP3R2 |
protein phosphatase 3 regulatory subunit B, beta |
5535 |
Q96LZ3 |
chr9: 101,591,615-101,595,021 |
PRKACA |
protein kinase, cAMP-dependent, alpha catalytic subunit |
5566 |
P17612 |
chr19: 14,091,688-14,118,084 |
MAPK8 |
mitogen-activated protein kinase 8 |
5599 |
P45983 |
chr10: 48,306,639-48,439,360 |
POLE4 |
polymerase (DNA-directed), epsilon 4, accessory subunit |
56655 |
Q9NR33 |
chr2: 74,958,492-74,970,128 |
POLD4 |
polymerase (DNA-directed), delta 4, accessory subunit |
57804 |
Q9HCU8 |
chr11: 67,350,777-67,356,972 |
BAX |
BCL2-associated X protein |
581 |
Q07812 |
chr19: 48,954,815-48,961,798 |
RANBP1 |
RAN binding protein 1 |
5902 |
P43487 |
chr22: 20,115,938-20,127,357 |
RB1 |
retinoblastoma 1 |
5925 |
P06400 |
chr13: 48,303,751-48,481,986 |
RELA |
v-rel avian reticuloendotheliosis viral oncogene homolog A |
5970 |
Q04206 |
chr11: 65,653,596-65,663,094 |
RELB |
v-rel avian reticuloendotheliosis viral oncogene homolog B |
5971 |
Q01201 |
chr19: 45,001,430-45,038,198 |
RRAS |
related RAS viral (r-ras) oncogene homolog |
6237 |
P10301 |
chr19: 49,635,292-49,640,201 |
ANAPC1 |
anaphase promoting complex subunit 1 |
64682 |
Q9H1A4 |
chr2: 111,766,271-111,884,690 |
CRTC3 |
CREB regulated transcription coactivator 3 |
64784 |
Q6UUV7 |
chr15: 90,529,925-90,645,345 |
SLC2A1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
6513 |
P11166 |
chr1: 42,925,375-42,959,173 |
STAT5A |
signal transducer and activator of transcription 5A |
6776 |
P42229 |
chr17: 42,287,547-42,311,943 |
STAT5B |
signal transducer and activator of transcription 5B |
6777 |
P51692 |
chr17: 42,199,168-42,276,707 |
TCF3 |
transcription factor 3 |
6929 |
P15923 |
chr19: 1,609,290-1,652,605 |
BUB1B |
BUB1B, mitotic checkpoint serine/threonine kinase |
701 |
O60566 |
chr15: 40,161,023-40,221,136 |
TGFB1 |
transforming growth factor beta 1 |
7040 |
P01137 |
chr19: 41,301,587-41,353,911 |
TGFB2 |
transforming growth factor beta 2 |
7042 |
P61812 |
chr1: 218,346,235-218,444,619 |
TGFBR1 |
transforming growth factor beta receptor I |
7046 |
P36897 |
chr9: 99,104,038-99,154,192 |
TGFBR2 |
transforming growth factor beta receptor II |
7048 |
P37173 |
chr3: 30,606,502-30,694,142 |
TSPO |
translocator protein |
706 |
P30536 |
chr22: 43,151,514-43,163,242 |
TLN1 |
talin 1 |
7094 |
Q9Y490 |
chr9: 35,696,948-35,732,395 |
TNF |
tumor necrosis factor |
7124 |
P01375 |
chr6: 31,575,567-31,578,336 |
TP53 |
tumor protein p53 |
7157 |
P04637 |
chr17: 7,661,779-7,687,550 |
VCAM1 |
vascular cell adhesion molecule 1 |
7412 |
P19320 |
chr1: 100,719,742-100,739,045 |
VDAC2 |
voltage-dependent anion channel 2 |
7417 |
P45880 |
chr10: 75,210,154-75,231,448 |
VDAC3 |
voltage-dependent anion channel 3 |
7419 |
Q9Y277 |
chr8: 42,391,624-42,405,897 |
WNT2 |
wingless-type MMTV integration site family member 2 |
7472 |
P09544 |
chr7: 117,276,631-117,323,289 |
WNT3 |
wingless-type MMTV integration site family member 3 |
7473 |
P56703 |
chr17: 46,762,506-46,833,154 |
WNT5A |
wingless-type MMTV integration site family member 5A |
7474 |
P41221 |
chr3: 55,465,715-55,490,539 |
WNT6 |
wingless-type MMTV integration site family member 6 |
7475 |
Q9Y6F9 |
chr2: 218,859,821-218,874,233 |
WNT2B |
wingless-type MMTV integration site family member 2B |
7482 |
Q93097 |
chr1: 112,466,541-112,530,165 |
XBP1 |
X-box binding protein 1 |
7494 |
P17861 |
chr22: 28,794,555-28,800,597 |
XPO1 |
exportin 1 |
7514 |
O14980 |
chr2: 61,477,849-61,538,626 |
ZFP36 |
ZFP36 ring finger protein |
7538 |
P26651 |
chr19: 39,406,813-39,409,412 |
IL1R2 |
interleukin 1 receptor, type II |
7850 |
P27930 |
chr2: 101,991,844-102,028,544 |
FOSL1 |
FOS-like antigen 1 |
8061 |
P15407 |
chr11: 65,892,049-65,900,573 |
WNT5B |
wingless-type MMTV integration site family member 5B |
81029 |
Q9H1J7 |
chr12: 1,529,891-1,647,243 |
CALR |
calreticulin |
811 |
P27797 |
chr19: 12,938,578-12,944,489 |
CANX |
calnexin |
821 |
P27824 |
chr5: 179,678,628-179,730,925 |
TRRAP |
transformation/transcription domain-associated protein |
8295 |
Q9Y4A5 |
chr7: 98,877,933-99,013,243 |
FZD4 |
frizzled class receptor 4 |
8322 |
Q9ULV1 |
chr11: 86,945,679-86,955,391 |
FZD6 |
frizzled class receptor 6 |
8323 |
O60353 |
chr8: 103,298,433-103,332,866 |
FZD7 |
frizzled class receptor 7 |
8324 |
O75084 |
chr2: 202,034,587-202,038,445 |
FZD8 |
frizzled class receptor 8 |
8325 |
Q9H461 |
chr10: 35,638,249-35,642,278 |
CDC23 |
cell division cycle 23 |
8697 |
Q9UJX2 |
chr5: 138,187,648-138,213,343 |
NRP1 |
neuropilin 1 |
8829 |
O14786 |
chr10: 33,177,492-33,336,262 |
KAT2B |
K(lysine) acetyltransferase 2B |
8850 |
Q92831 |
chr3: 20,040,023-20,154,404 |
CCND2 |
cyclin D2 |
894 |
P30279 |
chr12: 4,273,772-4,305,350 |
CCND3 |
cyclin D3 |
896 |
P30281 |
chr6: 41,934,933-42,050,357 |
CCNB2 |
cyclin B2 |
9133 |
O95067 |
chr15: 59,105,078-59,125,045 |
BUB3 |
BUB3 mitotic checkpoint protein |
9184 |
O43684 |
chr10: 123,154,277-123,170,467 |
PTTG1 |
pituitary tumor-transforming 1 |
9232 |
O95997 |
chr5: 160,421,822-160,428,744 |
TP53INP1 |
tumor protein p53 inducible nuclear protein 1 |
94241 |
Q96A56 |
chr8: 94,925,972-94,949,411 |
CDC20 |
cell division cycle 20 |
991 |
Q12834 |
chr1: 43,358,955-43,363,203 |
CDC27 |
cell division cycle 27 |
996 |
P30260 |
chr17: 47,117,703-47,189,422 |